Hepatocellular Carcinoma by BCLC Stage — Trials

Hepatocellular Carcinoma by BCLC Stage — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04777708	BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer	terminated	Early Phase 1	1	Jonsson Comprehensive Cancer CenterOTHER	1	Mar 24, 2023	clinicaltrials

Data updated 22 days agoSource updated Mar 24, 2023source: clinicaltrials